Table 5.

Adverse Events

Variable	Value, n (%)
Total	172
Any adverse event*	76 of 172 (44.2)
Bradycardia	3 of 162 (1.9)
Age 0 to <3 yr (<100 bpm)	3 of 134 (2.2)
Age 3 to <9 yr (<60 bpm)	0 of 10
Age 9–17 yr (<50 bpm)	0 of 18
Hypotension†	39 of 172 (22.7)
SBP and age definition	25 of 39 (64.1)
Fluid bolus (>5 mL/kg)	19 of 39 (48.7)
Vasopressor initiation	9 of 39 (23.1)
Hypertension	42 of 172 (24.4)
SBP or MAP increase by 20%‡	41 of 116 (35.3)
Antihypertensive initiated	1 of 172 (0.6)
Adrenal insufficiency	21 of 172 (12.2)
Hyperkalemia	3 of 166 (1.8)
Severe hyperkalemia	4 of 166 (2.4)
Cardiac arrest	2 of 172 (1.2)
Chest wall rigidity	1 of 172 (0.6)

MAP, mean arterial pressure; SBP, systolic blood pressure

* Some patients had multiple adverse events occur.

^† Some met multiple criteria.

^‡ SBP or MAP at baseline and within 60 minutes after RSI was only available in 116 patients.